Nuclease-based genome editing has proven to be a powerful and promising tool for disease modeling and gene therapy. Recent advances in CRISPR/Cas and TALE indicate that they could also be used as a targeted regulator of gene expression, as well as being utilized for illuminating specific chromosomal structures or genomic regions.
CITATION STYLE
Deng, L., Ren, R., Wu, J., Suzuki, K., Izpisua Belmote, J. C., & Liu, G. H. (2015). CRISPR/Cas9 and TALE: beyond cut and paste. Protein and Cell, 6(3), 157–159. https://doi.org/10.1007/s13238-015-0137-5
Mendeley helps you to discover research relevant for your work.